Moderna has announced a $140 million investment to enhance its Massachusetts manufacturing capacity, a move that supports ...

Regeneron announced the FDA’s approval of two indications of Eylea HD, including an 8mg injection for patients with macular ...

Cancerguard, a multi-cancer early detection blood test.

In the first part of our conversation with Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings ...

Moderna's $140 million investment in Norwood, Massachusetts, aims to complete its U.S. manufacturing loop, enhancing ...

Just a few weeks after the company announced licensing agreements with Empirico and Syndivia, GSK announced a strategic ...

Learn how outdated or incomplete insights turn every decision into a high-stakes gamble that cost brands money, momentum, and ...

This series kicks off by introducing David Edelman, Founder & CEO of Thrivable, who joins Pharmaceutical Executive to discuss ...

David Edelman, Founder & CEO of Thrivable, provides an unflinching look at why today’s most relied-upon tools, including ...

UnitedHealth Group appoints Dr. Scott Gottlieb to its board, enhancing leadership amongst a time in which the company looks ...

Understand how real-time patient intelligence transforms leadership conversations from speculation and opinion battles into ...

Alkermes’ $1.50 CVR price is contingent upon approval for Avadel’s leading treatment candidate for idiopathic hypersomnia in ...